Pentraxin-3 concentration in gingival crevicular fluid

Effect of non-surgical periodontal therapy on pentraxin-3 concentration in gingival crevicular fluid of chronic periodontitis patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190717044253N1

Enrollment

Registered

2019-08-28

Start date

2017-09-10

Completion date

Unknown

Last updated

2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Generalized moderate chronic periodontitis.

Interventions

Intervention 1: Control group: receive no treatment. Intervention 2: Participants receive oral hygiene instructions (the rolling method twice a day) .Phase I periodontal therapy is performed for perio

Eligibility

Sex/Gender

All

Age

25 Years to 50 Years

Inclusion criteria

Inclusion criteria: 25 to 50 years Patients with moderate periodontitis (patient group) No history of periodontal disease (control group)

Exclusion criteria

Exclusion criteria: Systemic conditions such as respiratory and cardiovascular diseases, diabetes mellitus, HIV, chemotherapy, pregnancy or nursing Antibiotic therapy, medication intake in the past 6 months, Smokers Infectious diseases and any sign/symptom of infection. Periodontal treatment in the past 6 months

Design outcomes

Primary

Measure	Time frame
Level of pentraxin-3 in gingival crevicular fluid. Timepoint: At the beginning of the study and 6 weeks after scaling and rootplaning. Method of measurement: enzyme-linked immunosorbent assay.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahtab Samieifar

Qazvin University of Medical Sciences

m.samieifar@qums.ac.ir+98 28 3335 1408

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026